Theravance Biopharma, Inc.TBPHNASDAQ
Loading
Total earnings after all expenses, taxes, and interest
3Y CAGR
-50.5%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $105.89M | +287.7% |
| 2024 | $-56.42M | -2.2% |
| 2023 | $-55.19M | -106.3% |
| 2022 | $872.13M | +537.3% |
| 2021 | $-199.43M | +28.3% |
| 2020 | $-278.02M | -17.6% |
| 2019 | $-236.46M | -9.7% |
| 2018 | $-215.52M | +24.5% |
| 2017 | $-285.40M | -49.7% |
| 2016 | $-190.67M | - |